Articles
Special Challenges In Production Of Biopharmaceutical Dosage Forms
April 17, 2009
Click Here To Download:
•Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
•Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
•Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
By Michael J. Akers
Biopharmaceutical products are potent, reactive, unstable, and expensive. As a consequence, all aspects of their handling, identity control, processing, packaging, and storage require utmost attention, if not perfection.
When mistakes occur during one or more segments of biopharmaceutical dosage form production, companies lose precious time and spend valuable resources investigating and controlling the impact of those mistakes on good manufacturing practice (GMP) attributes including safety, identity, strength, purity, and quality.
Reprinted with permission from BioProcess International 4(11):36-43 (December 2006)
Click Here To Download:•Article: Special Challenges In Production Of Biopharmaceutical Dosage Forms
